Literature DB >> 23052595

Clinical evolution of seizures: distribution across time of day and sleep/wakefulness cycle.

Iván Sánchez Fernández1, Sriram Ramgopal, Christine Powell, Matt Gregas, Marcin Zarowski, Aneri Shah, Martina Vendrame, Andreas V Alexopoulos, Sanjeev V Kothare, Tobias Loddenkemper.   

Abstract

Seizures can evolve sequentially into different clinical phases. For example, a seizure may start as an aura (first phase), then evolve into a tonic seizure (second phase), and evolve further into a generalized tonic-clonic semiology (third phase). It is currently unknown whether specific seizure evolutions cluster at particular times of the day and/or during sleep/wakefulness. We aimed to describe the distribution of the clinical evolution of seizures across time of day and sleep/wake state. We included all patients with at least two seizure phases admitted for long-term electroencephalogram monitoring during a 5 year period. Two-hundred-and-fifteen patients (866 seizures) presented with two different phases and 87 patients (324 seizures) evolved into a third clinical phase. During phase two, evolution into clonic seizures differed across time (p = 0.047) with peaks at 0-3 h and 6-9 h and during sleep (p < 0.001), evolution into automotor seizures peaked during wakefulness (p = 0.015), evolution into tonic seizures differed across time (p = 0.005) with peaks at 21-12 h and during sleep (p = 0.0119), and generalized tonic-clonic seizures peaked during sleep (p = 0.0067). Findings remained statistically significant after multivariable analysis adjusting, separately, for potential confounders (semiology of the first phase, age, gender, days in the long-term electroencephalographic monitoring unit, abnormal neuroimaging, number of antiepileptic medications, and seizure localization). During phase three, seizure evolutions followed the same pattern of distribution as during phase two but differences did not reach statistical significance. Our data demonstrate that the evolution of seizures into different phases cluster at specific times of day and at specific phases of the sleep/wakefulness cycle.

Entities:  

Mesh:

Year:  2012        PMID: 23052595     DOI: 10.1007/s00415-012-6675-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  19 in total

1.  Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology.

Authors:  W T Blume; H O Lüders; E Mizrahi; C Tassinari; W van Emde Boas; J Engel
Journal:  Epilepsia       Date:  2001-09       Impact factor: 5.864

Review 2.  The epidemiology of epilepsy in Europe - a systematic review.

Authors:  L Forsgren; E Beghi; A Oun; M Sillanpää
Journal:  Eur J Neurol       Date:  2005-04       Impact factor: 6.089

Review 3.  The descriptive epidemiology of epilepsy-a review.

Authors:  Poonam Nina Banerjee; David Filippi; W Allen Hauser
Journal:  Epilepsy Res       Date:  2009-04-15       Impact factor: 3.045

4.  Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients.

Authors:  Radha Yegnanarayan; Suryavanshi D Mahesh; Shashi Sangle
Journal:  Chronobiol Int       Date:  2006       Impact factor: 2.877

5.  Circadian patterns of pediatric seizures.

Authors:  T Loddenkemper; M Vendrame; M Zarowski; M Gregas; A V Alexopoulos; E Wyllie; S V Kothare
Journal:  Neurology       Date:  2011-01-11       Impact factor: 9.910

6.  Circadian distribution and sleep/wake patterns of generalized seizures in children.

Authors:  Marcin Zarowski; Tobias Loddenkemper; Martina Vendrame; Andreas V Alexopoulos; Elaine Wyllie; Sanjeev V Kothare
Journal:  Epilepsia       Date:  2011-03-22       Impact factor: 5.864

Review 7.  Chronobiology of epilepsy: diagnostic and therapeutic implications of chrono-epileptology.

Authors:  Tobias Loddenkemper; Steven W Lockley; Joseph Kaleyias; Sanjeev V Kothare
Journal:  J Clin Neurophysiol       Date:  2011-04       Impact factor: 2.177

Review 8.  Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota.

Authors:  W A Hauser; J F Annegers; W A Rocca
Journal:  Mayo Clin Proc       Date:  1996-06       Impact factor: 7.616

9.  Temporal distributions of seizure occurrence from various epileptogenic regions.

Authors:  T S Durazzo; S S Spencer; R B Duckrow; E J Novotny; D D Spencer; H P Zaveri
Journal:  Neurology       Date:  2008-04-08       Impact factor: 9.910

Review 10.  Epidemiology, aetiology, and clinical management of epilepsy in Asia: a systematic review.

Authors:  Tu Luong Mac; Duc-Si Tran; Fabrice Quet; Peter Odermatt; Pierre-Marie Preux; Chong Tin Tan
Journal:  Lancet Neurol       Date:  2007-06       Impact factor: 44.182

View more
  5 in total

Review 1.  An update in sleep neurology: the latest bedtime stories.

Authors:  K N Anderson
Journal:  J Neurol       Date:  2014-12-10       Impact factor: 4.849

2.  Circadian regulation of sleep in a pre-clinical model of Dravet syndrome: dynamics of sleep stage and siesta re-entrainment.

Authors:  Raymond E A Sanchez; Ivana L Bussi; Miriam Ben-Hamo; Carlos S Caldart; William A Catterall; Horacio O De La Iglesia
Journal:  Sleep       Date:  2019-12-24       Impact factor: 5.849

3.  CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development.

Authors:  Scott T Demarest; Heather E Olson; Angela Moss; Elia Pestana-Knight; Xiaoming Zhang; Sumit Parikh; Lindsay C Swanson; Katherine D Riley; Grace A Bazin; Katie Angione; Lisa-Marie Niestroj; Dennis Lal; Elizabeth Juarez-Colunga; Tim A Benke
Journal:  Epilepsia       Date:  2019-07-16       Impact factor: 5.864

Review 4.  Chronopharmacology of anti-convulsive therapy.

Authors:  Sriram Ramgopal; Sigride Thome-Souza; Tobias Loddenkemper
Journal:  Curr Neurol Neurosci Rep       Date:  2013-04       Impact factor: 5.081

5.  BMAL1 controls the diurnal rhythm and set point for electrical seizure threshold in mice.

Authors:  Jason R Gerstner; George G Smith; Olivia Lenz; Isaac J Perron; Russell J Buono; Thomas N Ferraro
Journal:  Front Syst Neurosci       Date:  2014-06-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.